fda glp-1 warning september 2025 news and Novo Nordisk Warned of Telehealth Compounding Takedown. What's Next? FDA Sends Warning Letters to

10.1530/EJE-18-0076 146 VeldhuisJ

As a result of using Defendants Ozempic and Mounjaro, Plaintiff was caused to suffer from severe gastrointestinal events, which resulted in, for example, severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting, and throwing up whole food hours after eating, the lawsuit claims

All patients had subjective or measured fever and more than half reported rash, abdominal pain, vomiting or diarrhea

Ye Z, Zhuo Q, Hu Q, Xu X, Mengqi L, Zhang Z, et al

GHRH analogs including CJC 1295 and growth hormone releasing peptides including ipamorelin are listed under WADA's Prohibited List in the peptide hormone category

Vilsbll T, Krarup T, Deacon CF, Madsbad S, Holst JJ